CorMedix Inc. (CRMD)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Joseph Todisco MBA | CEO & Director | 1.07M | -- | 1977 |
| Dr. Matthew T. David M.D. | Executive VP & CFO | 597.27k | -- | 1979 |
| Ms. Erin Mistry | Executive VP & Chief Commercial Officer | 561.57k | -- | 1983 |
| Ms. Elizabeth Masson-Hurlburt B.A. | Executive VP and Chief Clinical Strategy & Operations Officer | 538.91k | -- | 1980 |
| Ms. Kaufman Beth Zelnick Esq. | Executive VP, Chief Legal Officer & Corporate Secretary | -- | -- | -- |
| Donna Ucci | Senior VP & Head of Global Quality | -- | -- | -- |
| Dr. Tushar Mukherjee | Senior VP & Head of Technical Operations | -- | -- | -- |
CorMedix Inc.
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 82
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Corporate Governance
Upcoming Events
November 12, 2024 at 9:00 PM UTC - November 18, 2024 at 9:00 PM UTC
CorMedix Inc. Earnings Date
Recent Events
May 20, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission